{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:27:43Z","timestamp":1778808463806,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Ministry of Education and Science Fellowship"},{"name":"Canadian Network on Hepatitis C Fellowship"},{"name":"Alison and Steve Krausz Innovation Fund","award":["U19AI109662"],"award-info":[{"award-number":["U19AI109662"]}]},{"name":"NIH Director's Pioneer Award"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.coviro.2016.09.011","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T20:48:17Z","timestamp":1476737297000},"page":"106-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["My Cousin, My Enemy: quasispecies suppression of drug resistance"],"prefix":"10.1016","volume":"20","author":[{"given":"Karla","family":"Kirkegaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"van Buuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2016.09.011_bib0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virusres.2004.11.004","article-title":"Incorporation fidelity of the viral RNA-dependent RNA polymerase: a kinetic, thermodynamic and structural perspective","volume":"107","author":"Castro","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2016.09.011_bib0200","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral mutation rates","volume":"84","author":"Sanjuan","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.011_sbref0205","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nature12861","article-title":"Mutational and fitness landscapes of an RNA virus revealed through population sequencing","volume":"505","author":"Acevedo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.09.011_bib0210","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/hep.21809","article-title":"Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B","volume":"46","author":"Fernandes","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2016.09.011_bib0215","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1128\/AAC.01236-09","article-title":"Mechanism of resistance of hepatitis C virus replicons to structurally distinct cyclophilin inhibitors","volume":"54","author":"Puyang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.09.011_bib0220","doi-asserted-by":"crossref","first-page":"19104","DOI":"10.1074\/jbc.M115.644419","article-title":"A proline-tryptophan turn in the intrinsically disordered domain 2 of NS5A protein is essential for hepatitis C virus RNA replication","volume":"290","author":"Dujardin","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2016.09.011_bib0225","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cid\/ciu697","article-title":"Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with Sofosbuvir in phase 2 and 3 clinical trials","volume":"59","author":"Svarovskaia","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2016.09.011_sbref0230","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1128\/AAC.00581-16","article-title":"Barrier-independent, fitness-associated differences in Sofosbuvir efficacy against hepatitis C virus","volume":"60","author":"Gallego","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.09.011_bib0235","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1128\/jvi.63.12.5030-5036.1989","article-title":"Virus mutation frequencies can be greatly underestimated by monoclonal antibody neutralization of virions","volume":"63","author":"Holland","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.011_sbref0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03830","article-title":"Dominant drug targets suppress the emergence of antiviral resistance","volume":"3","author":"Tanner","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.coviro.2016.09.011_sbref0245","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01960-15","article-title":"Suppression of drug resistance in dengue virus","volume":"6","author":"Mateo","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.coviro.2016.09.011_bib0250","doi-asserted-by":"crossref","first-page":"e1005986","DOI":"10.1371\/journal.pgen.1005986","article-title":"Exploiting genetic interference for antiviral therapy","volume":"12","author":"Tanner","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1016\/j.coviro.2016.09.011_bib0255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/329219a0","article-title":"Functional inactivation of genes by dominant negative mutations","volume":"329","author":"Herskowitz","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.09.011_bib0260","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1128\/JVI.01267-13","article-title":"Refrex-1, a soluble restriction factor against feline endogenous and exogenous retroviruses","volume":"87","author":"Ito","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.011_sbref0265","doi-asserted-by":"crossref","first-page":"13175","DOI":"10.1073\/pnas.1407046111","article-title":"Inhibition of Borna disease virus replication by an endogenous bornavirus-like element in the ground squirrel genome","volume":"111","author":"Fujino","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.09.011_bib0270","doi-asserted-by":"crossref","first-page":"e1002015","DOI":"10.1371\/journal.pcbi.1002015","article-title":"Autonomous targeting of infectious superspreaders using engineered transmissible therapies","volume":"7","author":"Metzger","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coviro.2016.09.011_bib0275","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.200507075","article-title":"Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion","volume":"171","author":"Liao","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.coviro.2016.09.011_bib0280","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/viro.2001.0944","article-title":"Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1","volume":"286","author":"Iwatani","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.09.011_bib0285","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0092-8674(89)90874-X","article-title":"HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus","volume":"59","author":"Trono","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2016.09.011_bib0290","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2010.01.028","article-title":"The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation","volume":"400","author":"Checkley","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.09.011_bib0295","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1099\/vir.0.80006-0","article-title":"Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon","volume":"85","author":"Graziani","year":"2004","journal-title":"J Gen Virol"},{"issue":"Pt 8","key":"10.1016\/j.coviro.2016.09.011_bib0300","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1099\/0022-1317-77-8-1745","article-title":"Mutational analysis of the influenza virus A\/Victoria\/3\/75 PA protein: studies of interaction with PB1 protein and identification of a dominant negative mutant","volume":"77","author":"Zurcher","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.09.011_bib0305","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jmb.2013.12.031","article-title":"Distinct conformations of a putative translocation element in poliovirus polymerase","volume":"426","author":"Sholders","year":"2014","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coviro.2016.09.011_bib0310","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ng1583","article-title":"Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses","volume":"37","author":"Crowder","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.coviro.2016.09.011_bib0315","doi-asserted-by":"crossref","first-page":"8540","DOI":"10.1128\/JVI.00522-15","article-title":"Primer ID validates template sampling depth and greatly reduces the error rate of next-generation sequencing of HIV-1 genomic RNA populations","volume":"89","author":"Zhou","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.09.011_bib0320","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02964535","article-title":"A role for hemispheric asymmetry in human behavioral variability","volume":"24","author":"Drake","year":"1989","journal-title":"Pavlov J Biol Sci"},{"key":"10.1016\/j.coviro.2016.09.011_bib0325","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09945","article-title":"RNA polymerase errors cause splicing defects and can be regulated by differential expression of RNA polymerase subunits","volume":"4","author":"Carey","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.coviro.2016.09.011_bib0330","doi-asserted-by":"crossref","first-page":"13803","DOI":"10.1073\/pnas.2436299100","article-title":"Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis","volume":"100","author":"Mourez","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.09.011_bib0335","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semcancer.2013.06.002","article-title":"Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks","volume":"23","author":"Wang","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.coviro.2016.09.011_bib0340","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrc2656","article-title":"Novel anticancer targets: revisiting ERBB2 and discovering ERBB3","volume":"9","author":"Baselga","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.coviro.2016.09.011_bib0345","doi-asserted-by":"crossref","first-page":"e1004817","DOI":"10.1371\/journal.ppat.1004817","article-title":"Hepatitis C virus RNA replication depends on specific cis- and trans-acting activities of viral nonstructural proteins","volume":"11","author":"Kazakov","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.09.011_bib0350","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/jvi.60.2.793-796.1986","article-title":"Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: mutations in polypeptide 2C are directly responsible for altered guanidine sensitivity","volume":"60","author":"Pincus","year":"1986","journal-title":"J Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2016.09.011_bib0355","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1093\/infdis\/jiu043","article-title":"Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication","volume":"210","author":"McKinlay","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.09.011_bib0360","doi-asserted-by":"crossref","first-page":"e0004695","DOI":"10.1371\/journal.pntd.0004695","article-title":"The viral polymerase inhibitor 7-deaza-2\u2032-C-methyladenosine is a potent inhibitor of in vitro zika virus replication and delays disease progression in a robust mouse infection model","volume":"10","author":"Zmurko","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coviro.2016.09.011_bib0365","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/511310","article-title":"A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs","volume":"195","author":"Schul","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.09.011_bib0370","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/AAC.01032-08","article-title":"Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees","volume":"53","author":"Carroll","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.09.011_bib0375","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.01429-12","article-title":"A novel inhibitor of dengue virus replication that targets the capsid protein","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.09.011_bib0380","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1128\/JVI.01745-14","article-title":"Characterization of the mode of action of a potent dengue virus capsid inhibitor","volume":"88","author":"Scaturro","year":"2014","journal-title":"J Virol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716301432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716301432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T17:18:43Z","timestamp":1706375923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625716301432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":38,"alternative-id":["S1879625716301432"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2016.09.011","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"My Cousin, My Enemy: quasispecies suppression of drug resistance","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2016.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}